Neuropolybin: A new antiseizure peptide obtained from wasp venom.
Antiepileptic drugs (AED)
Encephalography (EEG)
Epilepsy
Neuropeptides
Pentylenetetrazole (PTZ)
Wasp venom
Journal
Biochemical pharmacology
ISSN: 1873-2968
Titre abrégé: Biochem Pharmacol
Pays: England
ID NLM: 0101032
Informations de publication
Date de publication:
11 2020
11 2020
Historique:
received:
31
03
2020
revised:
18
06
2020
accepted:
19
06
2020
pubmed:
27
6
2020
medline:
5
1
2021
entrez:
27
6
2020
Statut:
ppublish
Résumé
Epilepsy accounts for one of the most serious neurological disorders, and its treatment remains a challenge, due to high cost and harmful side effects. Bioactive molecules extracted from arthropod venoms are considered a promising therapy since these compounds are known for their highly selective and potent profiles. The purpose of this study was to identify and characterize the potential antiseizure effect of the peptide Ppnp7, extracted from the venom of the social wasp Polybia paulista, and also the effect of the bioinspired peptide, named Neuropolybin, in the same parameters. Additionally, we also evaluated the electroencephalographic (EEG) profile in the PTZ-induced acute seizures in animals treated with Neuropolybin, and potential adverse effects of both peptides in general spontaneous activity (Open Field analysis). Interestingly, Ppnp7 and Neuropolybin showed a noteworthy antiseizure effect in rats and mice, respectively. Curves of protection against the maximum seizure were obtained for both peptides, and EEG records demonstrated that Neuropolybin protected 80% of animals from tonic-clonic seizures when applied with a dose of 3 nmol (an approximate Ppnp7 ED
Identifiants
pubmed: 32589997
pii: S0006-2952(20)30355-5
doi: 10.1016/j.bcp.2020.114119
pii:
doi:
Substances chimiques
Anticonvulsants
0
Peptides
0
Wasp Venoms
0
Pentylenetetrazole
WM5Z385K7T
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
114119Informations de copyright
Copyright © 2020 Elsevier Inc. All rights reserved.